Form 4: Synergy CHC Grants 150,000 Stock Options to President
Insider Transaction Report
Synergy CHC Corp. granted 150,000 stock options to President and Director Alfred Baumeler with an exercise price of $2.38.
Summary
- Alfred Baumeler, President and Director of Synergy CHC Corp. (SNYR), was granted 150,000 stock options.
- The stock options have an exercise price of $2.38 per share.
- The grant date for these options is September 18, 2025.
- The options will expire on September 18, 2030.
- One-third (1/3) of the option grant vests on the first anniversary of the grant date.
- The remaining two-thirds (2/3) will vest in equal monthly installments over the subsequent twenty-four (24) months, contingent on Alfred Baumeler's continued service with the Company.
Sentiment
Score: 7
Explanation: The grant of stock options to a key executive is generally viewed positively as it aligns management's interests with shareholders, providing an incentive for long-term performance. It is a routine compensation event and does not indicate immediate financial performance changes.
Positives
- The stock option grant aligns the interests of President and Director Alfred Baumeler with those of shareholders, incentivizing long-term company performance.
- Provides a performance-based incentive for a key executive to contribute to the company's growth and share price appreciation.
Negatives
- Potential for future dilution of existing shareholder equity if the options are exercised.
Future Outlook
The vesting schedule for the stock options, extending over a three-year period, indicates an expectation of continued service from Alfred Baumeler and a long-term incentive structure for executive performance.
Industry Context
The grant of stock options to a key executive is a common practice in publicly traded companies across various industries, serving as a standard component of executive compensation packages designed to attract, retain, and motivate leadership by linking their financial success to the company's share price performance.
Related Party Transactions
- The stock option grant to Alfred Baumeler, a Director and President of Synergy CHC Corp., constitutes a related party transaction as it involves compensation provided to a key management personnel.
Stakeholder Impact
- Shareholders: Potential for long-term value creation through incentivized management, balanced against potential future dilution from option exercise.
- Employees (Alfred Baumeler): Enhanced compensation and long-term incentive tied to company performance.
Next Steps
- Vesting of one-third of the options on the first anniversary of the grant date (September 18, 2026).
- Subsequent monthly vesting of the remaining two-thirds of the options over the following 24 months, subject to continued service.
Key Dates
| Date | Description |
|---|---|
| 09/18/2025 | Date of earliest transaction (stock option grant date) and commencement of vesting period. |
| 09/22/2025 | Date the Form 4 filing was signed. |
| 09/18/2030 | Expiration date of the granted stock options. |
Recommendation
holdThis Form 4 filing reports a routine stock option grant to a key executive, which is a standard compensation practice designed to align management incentives with shareholder interests. It does not contain information that would significantly alter the investment thesis for Synergy CHC Corp. based solely on this disclosure, thus a 'hold' recommendation is appropriate.
Keywords
Synergy CHC Corp., SNYR, Stock Option Grant, Executive Compensation, Insider Transaction, Alfred Baumeler, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.